3Light RW. Pleural effusion. N Engl J Med 2002,346(25):1971～1977.
4Romero-Candeira S, Hernandez L, Romero-Brufao S et al. Is It Meaningful To Use BiochemicalParameters To Discriminate Between Transudative and Exudative Pleural Effusions? Chest.2002; 122:1524～ 1529.
5Aoe K,Hiraki A,Murakami T,et al. Diagnostic significance of Interferon-γ in tuberculous pleural effusions. Chest 2003, 123:740～744.
6Putnam, JB Jr. Malignant Pleural Effusions. Surgical Clinics of North America 2002;82(4) :867～883.
8Ferrer, J, Villarino, MA, Encabo, G, et al. Diagnostic utility of CYFRA21 - 1 ,carcinoembryonic antigen,CA 125, neuron specific enolase,and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 1999,86,1488～ 1495.
9Antunes G,Neville E, Duffy J,et al. BTS guidelines for the management of malignant pleural effusion. Thorax, 2003; 58 (Suppl Ⅱ ) :ii29～ii38.
10Fer rer J,Villarion MA,Tura JM,et al. Talc preparations used for pleurodesis vary markedly from one preparation to another.Chest 2001; 119:1901～5.
5Parulekar W,Di Prinio G,Matzinger F,et al.Use of small-bore vs large-bore chest tubes for treatment of malianant pleural effusions[J].Chest,2001,120(1):19-25.
6Sahin U,Unlü M,Akkaya A,et al.The value of small borecatheter thoracostomy in the treatnent of malignant pleuraleffusions[J].Respiration,2001,68(5):501-505.
